Biomolecular Life Holdings, Inc. SEC filings BIOM
Biomolecular Life Holdings, Inc. has 211 filings in SEC EDGAR's recent list, going back to Jul 29, 1999. Its latest annual report, Form 10-K, was filed on Apr 15, 2015 for the period ended Dec 31, 2014. The latest quarterly report (Form 10-Q) was filed on Nov 19, 2015, covering the quarter ended Sep 30, 2015. The most recent current report (Form 8-K) was filed on Mar 30, 2016 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Apr 15, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Aug 28, 2001 | May 31, 2001 |
| 10-K | Annual report | Aug 29, 2000 | May 31, 2000 |
Showing 3 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BIOM (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miami, FL
- SEC filer status
- Smaller reporting company
- SEC CIK
- 1091326
- Former names
- SB Technology Holdings, Inc. (until May 4, 2026); VG Life Sciences Inc. (until Mar 6, 2026); VG Life Sciences, Inc. (until Oct 14, 2014); VIRAL GENETICS INC /DE/ (until Mar 25, 2009); 5 STARLIVING ONLINE INC (until Oct 18, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.